Search for: "DOW PHARMACEUTICAL SCIENCES, INC."
Results 1 - 20
of 130
Sorted by Relevance
|
Sort by Date
8 Mar 2012, 6:44 pm
Longoria, Merrell Dow Pharmaceuticals, Inc. v. [read post]
5 Sep 2012, 5:26 am
("Intendis") and Dow Pharmaceutical Sciences, Inc. [read post]
8 Apr 2012, 8:51 pm
Stiefel Laboratories, Inc. et al. 2:12-cv-01746; filed March 20, 2012 in the District Court of New Jersey • Plaintiffs: Medicis Pharmaceutical Corp.; Dow Pharmaceutical Sciences, Inc. [read post]
17 Nov 2018, 12:10 pm
The amicus brief of the American Association for the Advancement of Science and the National Academy of Science was a good example of advocacy for the full implementation of gatekeeping on scientific principles of valid inference.1 Other amici urged an anything goes approach to judicial oversight of expert witnesses. [read post]
24 Mar 2009, 11:54 am
Merrell Dow Pharmaceuticals was a U.S. [read post]
28 Dec 2018, 2:22 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), appealed a Ninth Circuit ruling that the Frye rule survived, and was incorporated into, the enactment of a statutory evidentiary rule, Rule 702. [read post]
1 Oct 2020, 5:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), the Frye test was the predominant standard for the admissibility of scientific evidence in state and federal courts. [read post]
25 Oct 2011, 9:05 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 595 (1993), that “[e]xpert evidence can be both powerful and quite misleading because of the difficulty in evaluating it. [read post]
13 Jul 2019, 8:53 am
Merrell Dow Pharms., Inc., 509 U.S. 579, 595 (1993). [8] Bench Book at 10. [9] Id. at 10. [10] Id. at 10. [11] See State Justice Institute Act of 1984 (42 U.S.C. ch. 113, 42 U.S.C. [read post]
7 Sep 2020, 11:33 am
Merrell Dow Pharmaceuticals, Inc., the Supreme Court held that Federal Rule of Evidence superseded Frye’s general acceptance test. [read post]
18 Sep 2019, 10:02 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S. [read post]
17 Jan 2014, 8:27 pm
Merrell Dow Pharmaceuticals, Inc., the United States Supreme Court held for the first time that, to be admissible, scientific evidence must be both scientifically valid and properly applicable to the facts at issue in the case. [read post]
2 Jul 2013, 6:17 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), General Electric Co. v. [read post]
8 Jul 2011, 8:52 am
MERRELL DOW PHARMACEUTICALS, INC., laying down the foundation of admissibility of scientific expert testimony. [read post]
17 Jan 2014, 8:27 pm
Merrell Dow Pharmaceuticals, Inc., the United States Supreme Court held for the first time that, to be admissible, scientific evidence must be both scientifically valid and properly applicable to the facts at issue in the case. [read post]
25 Jan 2012, 6:42 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786 (1993), and discussed in Taylor v. [read post]
22 Mar 2010, 4:13 am
Dow Agro Sciences, et al. [read post]
23 Jan 2024, 3:43 am
Vanda Pharmaceuticals Inc., v. [read post]
17 Jun 2022, 2:09 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), legal scholars, judges, and lawyers have struggled with the structure and validity of expert opinion on specific causation. [read post]
7 Feb 2011, 9:24 am
Corporate profits are strong, and the Dow is north of 12,000. [read post]
